ArticleBlood advances2024

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.

Kristine A Frerichs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.